Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 476 entries
Sorted by: Best Match Show Resources per page
Learning disabilities among extremely preterm children without neurosensory impairment: Comorbidity, neuropsychological profiles and scholastic outcomes.

Early human development

Johnson S, Strauss V, Gilmore C, Jaekel J, Marlow N, Wolke D.
PMID: 27517525
Early Hum Dev. 2016 Dec;103:69-75. doi: 10.1016/j.earlhumdev.2016.07.009. Epub 2016 Aug 09.

BACKGROUND: Children born extremely preterm are at high risk for intellectual disability, learning disabilities, executive dysfunction and special educational needs, but little is understood about the comorbidity of intellectual and learning disabilities in this population.AIMS: This study explored comorbidity...

Cite
Johnson S, Strauss V, Gilmore C, et al. Learning disabilities among extremely preterm children without neurosensory impairment: Comorbidity, neuropsychological profiles and scholastic outcomes. Early Hum Dev. 2016;103:69-75doi: 10.1016/j.earlhumdev.2016.07.009.
Johnson, S., Strauss, V., Gilmore, C., Jaekel, J., Marlow, N., & Wolke, D. (2016). Learning disabilities among extremely preterm children without neurosensory impairment: Comorbidity, neuropsychological profiles and scholastic outcomes. Early human development, 10369-75. https://doi.org/10.1016/j.earlhumdev.2016.07.009
Johnson, Samantha, et al. "Learning disabilities among extremely preterm children without neurosensory impairment: Comorbidity, neuropsychological profiles and scholastic outcomes." Early human development vol. 103 (2016): 69-75. doi: https://doi.org/10.1016/j.earlhumdev.2016.07.009
Johnson S, Strauss V, Gilmore C, Jaekel J, Marlow N, Wolke D. Learning disabilities among extremely preterm children without neurosensory impairment: Comorbidity, neuropsychological profiles and scholastic outcomes. Early Hum Dev. 2016 Dec;103:69-75. doi: 10.1016/j.earlhumdev.2016.07.009. Epub 2016 Aug 09. PMID: 27517525.
Copy Download .nbib Format: NLM
Prevalence of sleep-disordered breathing in acute coronary syndrome: a systemic review and meta-analysis.

Sleep & breathing = Schlaf & Atmung

Huang Z, Zheng Z, Luo Y, Li S, Zhu J, Liu J.
PMID: 27549104
Sleep Breath. 2017 Mar;21(1):217-226. doi: 10.1007/s11325-016-1398-9. Epub 2016 Aug 22.

PURPOSE: This study aimed to review the literature on the prevalence of sleep-disordered breathing (SDB) in patients with acute coronary syndrome (ACS).METHODS: Relevant studies were searched on PubMed, EMBASE, and Cochrane Library through December 2014. Data were extracted using...

Cite
Huang Z, Zheng Z, Luo Y, et al. Prevalence of sleep-disordered breathing in acute coronary syndrome: a systemic review and meta-analysis. Sleep Breath. 2016;21(1):217-226doi: 10.1007/s11325-016-1398-9.
Huang, Z., Zheng, Z., Luo, Y., Li, S., Zhu, J., & Liu, J. (2017). Prevalence of sleep-disordered breathing in acute coronary syndrome: a systemic review and meta-analysis. Sleep & breathing = Schlaf & Atmung, 21(1), 217-226. https://doi.org/10.1007/s11325-016-1398-9
Huang, Zhuoshan, et al. "Prevalence of sleep-disordered breathing in acute coronary syndrome: a systemic review and meta-analysis." Sleep & breathing = Schlaf & Atmung vol. 21,1 (2017): 217-226. doi: https://doi.org/10.1007/s11325-016-1398-9
Huang Z, Zheng Z, Luo Y, Li S, Zhu J, Liu J. Prevalence of sleep-disordered breathing in acute coronary syndrome: a systemic review and meta-analysis. Sleep Breath. 2017 Mar;21(1):217-226. doi: 10.1007/s11325-016-1398-9. Epub 2016 Aug 22. PMID: 27549104.
Copy Download .nbib Format: NLM
Cross-disorder comparative analysis of comorbid conditions reveals novel autism candidate genes.

BMC genomics

Diaz-Beltran L, Esteban FJ, Varma M, Ortuzk A, David M, Wall DP.
PMID: 28427329
BMC Genomics. 2017 Apr 20;18(1):315. doi: 10.1186/s12864-017-3667-9.

BACKGROUND: Numerous studies have highlighted the elevated degree of comorbidity associated with autism spectrum disorder (ASD). These comorbid conditions may add further impairments to individuals with autism and are substantially more prevalent compared to neurotypical populations. These high rates...

Cite
Diaz-Beltran L, Esteban FJ, Varma M, et al. Cross-disorder comparative analysis of comorbid conditions reveals novel autism candidate genes. BMC Genomics. 2017;18(1):315doi: 10.1186/s12864-017-3667-9.
Diaz-Beltran, L., Esteban, F. J., Varma, M., Ortuzk, A., David, M., & Wall, D. P. (2017). Cross-disorder comparative analysis of comorbid conditions reveals novel autism candidate genes. BMC genomics, 18(1), 315. https://doi.org/10.1186/s12864-017-3667-9
Diaz-Beltran, Leticia, et al. "Cross-disorder comparative analysis of comorbid conditions reveals novel autism candidate genes." BMC genomics vol. 18,1 (2017): 315. doi: https://doi.org/10.1186/s12864-017-3667-9
Diaz-Beltran L, Esteban FJ, Varma M, Ortuzk A, David M, Wall DP. Cross-disorder comparative analysis of comorbid conditions reveals novel autism candidate genes. BMC Genomics. 2017 Apr 20;18(1):315. doi: 10.1186/s12864-017-3667-9. PMID: 28427329; PMCID: PMC5399393.
Copy Download .nbib Format: NLM
Walking the Narrow Path--Managing the Patient with Chronic Medical Illnesses.

The Medical clinics of North America

Paauw DS.
PMID: 26320051
Med Clin North Am. 2015 Sep;99(5):xvii-xviii. doi: 10.1016/j.mcna.2015.07.001.

No abstract available.

Cite
Paauw DS. Walking the Narrow Path--Managing the Patient with Chronic Medical Illnesses. Med Clin North Am. 2015;99(5):xvii-xviiidoi: 10.1016/j.mcna.2015.07.001.
Paauw, D. S. (2015). Walking the Narrow Path--Managing the Patient with Chronic Medical Illnesses. The Medical clinics of North America, 99(5), xvii-xviii. https://doi.org/10.1016/j.mcna.2015.07.001
Paauw, Douglas S. "Walking the Narrow Path--Managing the Patient with Chronic Medical Illnesses." The Medical clinics of North America vol. 99,5 (2015): xvii-xviii. doi: https://doi.org/10.1016/j.mcna.2015.07.001
Paauw DS. Walking the Narrow Path--Managing the Patient with Chronic Medical Illnesses. Med Clin North Am. 2015 Sep;99(5):xvii-xviii. doi: 10.1016/j.mcna.2015.07.001. PMID: 26320051.
Copy Download .nbib Format: NLM
[Multimorbidity management and the physician's daily clinical dilemma].

Der Internist

Battegay E, Cheetham M, Holzer BM, Nowak A, Schmidt D, Rampini S.
PMID: 28246687
Internist (Berl). 2017 Apr;58(4):344-353. doi: 10.1007/s00108-017-0200-9.

About 20-25% of all persons and about 90% of all patients who are acutely hospitalized in internal medicine departments have multiple acute or chronic diseases. They are multimorbid. The encounter with multimorbid patients has become the most common situation...

Cite
Battegay E, Cheetham M, Holzer BM, et al. Multimorbiditätsmanagement im Alltagsdilemma. [Multimorbidity management and the physician's daily clinical dilemma]. Internist (Berl). 2017;58(4):344-353doi: 10.1007/s00108-017-0200-9.
Battegay, E., Cheetham, M., Holzer, B. M., Nowak, A., Schmidt, D., & Rampini, S. (2017). Multimorbiditätsmanagement im Alltagsdilemma. [Multimorbidity management and the physician's daily clinical dilemma]. Der Internist, 58(4), 344-353. https://doi.org/10.1007/s00108-017-0200-9
Battegay, E, et al. "Multimorbiditätsmanagement im Alltagsdilemma." [Multimorbidity management and the physician's daily clinical dilemma]. Der Internist vol. 58,4 (2017): 344-353. doi: https://doi.org/10.1007/s00108-017-0200-9
Battegay E, Cheetham M, Holzer BM, Nowak A, Schmidt D, Rampini S. Multimorbiditätsmanagement im Alltagsdilemma. [Multimorbidity management and the physician's daily clinical dilemma]. Internist (Berl). 2017 Apr;58(4):344-353. doi: 10.1007/s00108-017-0200-9. German. PMID: 28246687.
Copy Download .nbib Format: NLM
Consensus Statement of the Indian Academy of Pediatrics on Evaluation and Management of Autism Spectrum Disorder.

Indian pediatrics

, Dalwai S, Ahmed S, Udani V, Mundkur N, Kamath SS, C Nair MK.
PMID: 28368272
Indian Pediatr. 2017 May 15;54(5):385-393. doi: 10.1007/s13312-017-1112-4. Epub 2017 Mar 29.

JUSTIFICATION: Autism Spectrum Disorder (ASD) is a clinically heterogenous condition with a wide range of etiological factors and causing significant public health burden. ASD poses a serious developmental disadvantage to the child in the form of poor schooling, social...

Cite
, Dalwai S, Ahmed S, et al. Consensus Statement of the Indian Academy of Pediatrics on Evaluation and Management of Autism Spectrum Disorder. Indian Pediatr. 2017;54(5):385-393doi: 10.1007/s13312-017-1112-4.
, Dalwai, S., Ahmed, S., Udani, V., Mundkur, N., Kamath, S. S., & C Nair, M. K. (2017). Consensus Statement of the Indian Academy of Pediatrics on Evaluation and Management of Autism Spectrum Disorder. Indian pediatrics, 54(5), 385-393. https://doi.org/10.1007/s13312-017-1112-4
, et al. "Consensus Statement of the Indian Academy of Pediatrics on Evaluation and Management of Autism Spectrum Disorder." Indian pediatrics vol. 54,5 (2017): 385-393. doi: https://doi.org/10.1007/s13312-017-1112-4
, Dalwai S, Ahmed S, Udani V, Mundkur N, Kamath SS, C Nair MK. Consensus Statement of the Indian Academy of Pediatrics on Evaluation and Management of Autism Spectrum Disorder. Indian Pediatr. 2017 May 15;54(5):385-393. doi: 10.1007/s13312-017-1112-4. Epub 2017 Mar 29. PMID: 28368272.
Copy Download .nbib Format: NLM
Capsule Commentary on Gallo et al., Multimorbidity, Depression, and Mortality in Primary Care: Randomized Clinical Trial of an Evidence-Based Depression Care Management Program on Mortality Risk.

Journal of general internal medicine

Jackson JL, Kay C.
PMID: 26857728
J Gen Intern Med. 2016 Apr;31(4):412. doi: 10.1007/s11606-016-3589-2.

No abstract available.

Cite
Jackson JL, Kay C. Capsule Commentary on Gallo et al., Multimorbidity, Depression, and Mortality in Primary Care: Randomized Clinical Trial of an Evidence-Based Depression Care Management Program on Mortality Risk. J Gen Intern Med. 2016;31(4):412doi: 10.1007/s11606-016-3589-2.
Jackson, J. L., & Kay, C. (2016). Capsule Commentary on Gallo et al., Multimorbidity, Depression, and Mortality in Primary Care: Randomized Clinical Trial of an Evidence-Based Depression Care Management Program on Mortality Risk. Journal of general internal medicine, 31(4), 412. https://doi.org/10.1007/s11606-016-3589-2
Jackson, Jeffrey L, and Kay, Cynthia. "Capsule Commentary on Gallo et al., Multimorbidity, Depression, and Mortality in Primary Care: Randomized Clinical Trial of an Evidence-Based Depression Care Management Program on Mortality Risk." Journal of general internal medicine vol. 31,4 (2016): 412. doi: https://doi.org/10.1007/s11606-016-3589-2
Jackson JL, Kay C. Capsule Commentary on Gallo et al., Multimorbidity, Depression, and Mortality in Primary Care: Randomized Clinical Trial of an Evidence-Based Depression Care Management Program on Mortality Risk. J Gen Intern Med. 2016 Apr;31(4):412. doi: 10.1007/s11606-016-3589-2. PMID: 26857728; PMCID: PMC4803698.
Copy Download .nbib Format: NLM
Multimorbidity: an endocrinologist looks at multi-level network disruption and at what gets diabetes?.

Journal of evaluation in clinical practice

Aron DC.
PMID: 27440485
J Eval Clin Pract. 2017 Feb;23(1):225-229. doi: 10.1111/jep.12600. Epub 2016 Jul 20.

No abstract available.

Cite
Aron DC. Multimorbidity: an endocrinologist looks at multi-level network disruption and at what gets diabetes?. J Eval Clin Pract. 2016;23(1):225-229doi: 10.1111/jep.12600.
Aron, D. C. (2017). Multimorbidity: an endocrinologist looks at multi-level network disruption and at what gets diabetes?. Journal of evaluation in clinical practice, 23(1), 225-229. https://doi.org/10.1111/jep.12600
Aron, David C. "Multimorbidity: an endocrinologist looks at multi-level network disruption and at what gets diabetes?." Journal of evaluation in clinical practice vol. 23,1 (2017): 225-229. doi: https://doi.org/10.1111/jep.12600
Aron DC. Multimorbidity: an endocrinologist looks at multi-level network disruption and at what gets diabetes?. J Eval Clin Pract. 2017 Feb;23(1):225-229. doi: 10.1111/jep.12600. Epub 2016 Jul 20. PMID: 27440485.
Copy Download .nbib Format: NLM
Syndemics: health in context.

Lancet (London, England)

The Lancet.
PMID: 28271823
Lancet. 2017 Mar 04;389(10072):881. doi: 10.1016/S0140-6736(17)30640-2.

No abstract available.

Cite
The Lancet. Syndemics: health in context. Lancet. 2017;389(10072):881doi: 10.1016/S0140-6736(17)30640-2.
The Lancet. (2017). Syndemics: health in context. Lancet (London, England), 389(10072), 881. https://doi.org/10.1016/S0140-6736(17)30640-2
The Lancet. "Syndemics: health in context." Lancet (London, England) vol. 389,10072 (2017): 881. doi: https://doi.org/10.1016/S0140-6736(17)30640-2
The Lancet. Syndemics: health in context. Lancet. 2017 Mar 04;389(10072):881. doi: 10.1016/S0140-6736(17)30640-2. PMID: 28271823.
Copy Download .nbib Format: NLM
Syndemics: committing to a healthier future.

Lancet (London, England)

Hart L, Horton R.
PMID: 28271826
Lancet. 2017 Mar 04;389(10072):888-889. doi: 10.1016/S0140-6736(17)30599-8.

No abstract available.

Cite
Hart L, Horton R. Syndemics: committing to a healthier future. Lancet. 2017;389(10072):888-889doi: 10.1016/S0140-6736(17)30599-8.
Hart, L., & Horton, R. (2017). Syndemics: committing to a healthier future. Lancet (London, England), 389(10072), 888-889. https://doi.org/10.1016/S0140-6736(17)30599-8
Hart, Laura, and Horton, Richard. "Syndemics: committing to a healthier future." Lancet (London, England) vol. 389,10072 (2017): 888-889. doi: https://doi.org/10.1016/S0140-6736(17)30599-8
Hart L, Horton R. Syndemics: committing to a healthier future. Lancet. 2017 Mar 04;389(10072):888-889. doi: 10.1016/S0140-6736(17)30599-8. PMID: 28271826.
Copy Download .nbib Format: NLM
Complications Within 30 Days of Hand Surgery: An Analysis of 10,646 Patients.

The Journal of hand surgery

Lipira AB, Sood RF, Tatman PD, Davis JI, Morrison SD, Ko JH.
PMID: 26235191
J Hand Surg Am. 2015 Sep;40(9):1852-59.e3. doi: 10.1016/j.jhsa.2015.06.103. Epub 2015 Jul 30.

PURPOSE: The American College of Surgeons Surgical Quality Improvement Program database collects detailed and validated data on demographics, comorbidities, and 30-day postoperative outcomes of patients undergoing operations in most subspecialties. This dataset has been previously used to quantify complications...

Cite
Lipira AB, Sood RF, Tatman PD, et al. Complications Within 30 Days of Hand Surgery: An Analysis of 10,646 Patients. J Hand Surg Am. 2015;40(9):1852-59.e3doi: 10.1016/j.jhsa.2015.06.103.
Lipira, A. B., Sood, R. F., Tatman, P. D., Davis, J. I., Morrison, S. D., & Ko, J. H. (2015). Complications Within 30 Days of Hand Surgery: An Analysis of 10,646 Patients. The Journal of hand surgery, 40(9), 1852-59.e3. https://doi.org/10.1016/j.jhsa.2015.06.103
Lipira, Angelo B, et al. "Complications Within 30 Days of Hand Surgery: An Analysis of 10,646 Patients." The Journal of hand surgery vol. 40,9 (2015): 1852-59.e3. doi: https://doi.org/10.1016/j.jhsa.2015.06.103
Lipira AB, Sood RF, Tatman PD, Davis JI, Morrison SD, Ko JH. Complications Within 30 Days of Hand Surgery: An Analysis of 10,646 Patients. J Hand Surg Am. 2015 Sep;40(9):1852-59.e3. doi: 10.1016/j.jhsa.2015.06.103. Epub 2015 Jul 30. PMID: 26235191.
Copy Download .nbib Format: NLM
Comorbidities in chronic obstructive pulmonary disease from assessment to treatment.

BioMed research international

Clini EM, Boschetto P, Lainscak M, Janssens W.
PMID: 24804221
Biomed Res Int. 2014;2014:414928. doi: 10.1155/2014/414928. Epub 2014 Apr 02.

No abstract available.

Cite
Clini EM, Boschetto P, Lainscak M, et al. Comorbidities in chronic obstructive pulmonary disease from assessment to treatment. Biomed Res Int. 2014;2014:414928doi: 10.1155/2014/414928.
Clini, E. M., Boschetto, P., Lainscak, M., & Janssens, W. (2014). Comorbidities in chronic obstructive pulmonary disease from assessment to treatment. BioMed research international, 2014414928. https://doi.org/10.1155/2014/414928
Clini, Enrico M, et al. "Comorbidities in chronic obstructive pulmonary disease from assessment to treatment." BioMed research international vol. 2014 (2014): 414928. doi: https://doi.org/10.1155/2014/414928
Clini EM, Boschetto P, Lainscak M, Janssens W. Comorbidities in chronic obstructive pulmonary disease from assessment to treatment. Biomed Res Int. 2014;2014:414928. doi: 10.1155/2014/414928. Epub 2014 Apr 02. PMID: 24804221; PMCID: PMC3996909.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 476 entries